PRETREATMENT WITH BETA-FUNALTREXAMINE BLOCKS MORPHINE-MEDIATED SUPPRESSION OF CTL ACTIVITY IN ALLOIMMUNIZED MICE

被引:22
作者
CARPENTER, GW
CARR, DJJ
机构
[1] LOUISIANA STATE UNIV,MED CTR,DEPT MICROBIOL,NEW ORLEANS,LA 70112
[2] LOUISIANA STATE UNIV,MED CTR,DEPT IMMUNOL,NEW ORLEANS,LA 70112
[3] LOUISIANA STATE UNIV,MED CTR,DEPT PARASITOL,NEW ORLEANS,LA 70112
[4] LOUISIANA STATE UNIV,MED CTR,DEPT PHARMACOL,NEW ORLEANS,LA 70112
[5] LOUISIANA STATE UNIV,MED CTR,CTR NEUROSCI,NEW ORLEANS,LA 70112
[6] LOUISIANA STATE UNIV,MED CTR,CTR ALCOHOL & DRUG ABUSE,NEW ORLEANS,LA 70112
来源
IMMUNOPHARMACOLOGY | 1995年 / 29卷 / 02期
关键词
CYTOTOXIC T LYMPHOCYTE; MORPHINE; NATURAL KILLER ACTIVITY; BETA-FUNALTREXAMINE;
D O I
10.1016/0162-3109(94)00052-H
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of prolonged exposure to morphine on cytotoxic T lymphocytes (CTL) and splenic natural killer (NK) activity was investigated. Daily administration of morphine (50.0 mg/kg, s.c.) to alloimmunized mice for 11 days resulted in a significant decrease (25-50%) in peritoneal and splenic CTL activity but not splenic NK activity. To identify the effector cell population mediating cytolysis, cell enrichment studies were carried out. The results of these studies indicated the CTLs are CD8(+) CD4(-). Chronic morphine treatment increased the percentage (25-30%) of CD3(+) CD4(+) and CD8(+) but not Ig(+) cells in the spleen relative to saline-treated controls. Pretreatment of mice with the mu-selective antagonist, beta-funaltrexamine blocked morphine-mediated suppression of splenic and peritoneal CTL activity as well as the increase in CD3(+)CD4(+) and CD8(+) splenic lymphocytes. These results indicate the generation of CTLs in vivo is sensitive to chronic morphine exposure implicating opiates as important co-factors through modulation of cell-mediated immunity.
引用
收藏
页码:129 / 140
页数:12
相关论文
共 55 条
[1]  
ADLER MW, 1993, ADV EXP MED BIOL, V335, P13
[2]   MORPHINE-INDUCED IMMUNE ALTERATIONS INVIVO [J].
ARORA, PK ;
FRIDE, E ;
PETITTO, J ;
WAGGIE, K ;
SKOLNICK, P .
CELLULAR IMMUNOLOGY, 1990, 126 (02) :343-353
[3]  
BADDLEY JW, 1993, ADV BIOSCI, V86, P593
[4]  
BAND LC, 1992, PROG NEUROENDOCRINIM, V5, P95
[5]  
BASS HZ, 1993, J IMMUNOL, V151, P2895
[6]   MORPHINE-INHIBITION OF LYMPHOCYTE ACTIVITY IS MEDIATED BY AN OPIOID DEPENDENT MECHANISM [J].
BAYER, BM ;
DAUSSIN, S ;
HERNANDEZ, M ;
IRVIN, L .
NEUROPHARMACOLOGY, 1990, 29 (04) :369-374
[7]  
BERGE G, 1994, ANNU REV IMMUNOL, V12, P735
[8]   MORPHINE-INDUCED IMMUNOMODULATION IS NOT RELATED TO SERUM MORPHINE CONCENTRATIONS [J].
BRYANT, HU ;
YOBURN, BC ;
INTURRISI, CE ;
BERNTON, EW ;
HOLADAY, JW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (1-2) :165-169
[9]   IMMUNOSUPPRESSIVE EFFECTS OF CHRONIC MORPHINE TREATMENT IN MICE [J].
BRYANT, HU ;
BERNTON, EW ;
HOLADAY, JW .
LIFE SCIENCES, 1987, 41 (14) :1731-1738
[10]  
BRYANT HU, 1990, J PHARMACOL EXP THER, V255, P410